A vaccine designed to fight severe acute respiratory syndrome (SARS) and technological advances in vaccine platforms are likely to speed up the time it will take to develop a vaccine for the new coronavirus, reported MarketWatch.
"I'm reasonably confident that within three months or less we'll be in a Phase 1 trial" for a coronavirus vaccine, which would be record speed for this type of trial, said Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID).
"The next four weeks to five weeks are going to be critical," Fauci said, adding that "it's either going to start peaking and going on a downturn, or it's going to explode into a global outbreak."
The World Health Organization's Emergency Committee said it would meet again on January 30 to discuss whether the outbreak is a "public health emergency of international concern."
According to the news source, researchers developed a vaccine for SARS that was eventually tested in a Phase I trial in 10 healthy adults, but by the time it had gone through an early-stage trial, the severity of the outbreak had declined, and it was no longer of use.
It took seven months to publish the SARS sequence in May 2003 after the first case of pneumonia was reported in China in late 2002. The Chinese government published the full genomic sequence for this coronavirus on January 10.
To read more NewsPoints articles, click here.